Emerging gram-positive bacterial infections

Clinics in Laboratory Medicine

Volumn 24, Issue 3, 2004, Pages 587-603

  Elsayed, Sameer ^a,b   Laupland, Kevin B ^a,c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d CALGARY HEALTH REGION   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COAGULASE; COTRIMOXAZOLE; CREATINE KINASE; CREATININE; ENDOTOXIN; ERYTHROMYCIN; HYALURONIDASE; LIVER ENZYME; MACROLIDE; PENICILLIN G; PROTEIN A; STAPHYLOCOCCUS ENTEROTOXIN; STREPTOLYSIN O; STREPTOLYSIN S; TETRACYCLINE; UREIDOPENICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CANCER CHEMOTHERAPY; CLOSTRIDIUM; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DRUG MEGADOSE; ENZYME ASSAY; FISH; FOOD POISONING; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; LISTERIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROFLORA; NECROTIZING FASCIITIS; NEONATAL TOXIC SHOCK SYNDROME LIKE EXANTHEMATOUS DISEASE; NEWBORN INFECTION; NOCARDIA; NONHUMAN; OSTEOMYELITIS; PHARYNGITIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; RHEUMATIC FEVER; SCARLET FEVER; SEPTICEMIA; SKIN INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS XYLOSUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; STREPTOCOCCUS INIAE; STREPTOCOCCUS PYOGENES; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME; TRANSPLANTATION;

COMMUNICABLE DISEASES, EMERGING; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS;

EID: 8444239997     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.05.007     Document Type: Review

References (50)

1. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. 1994;U.S. Department of Health and Human Services, Public Health Service, Atlanta (GA)
2. Levins R., members of the Harvard Working Group on New and Resurgent Diseases. The emergence of new diseases. Am Sci. 82:(1):1994;52-59
3. Laupland K.B., Gregson D.B., Zygun D.A., Doig C.J., Mortis G., Church D.L. Severe bloodstream infections: a population-based assessment. Crit Care Med. 32:(4):2004;992-997
4. Sheagren J.N., Schabert D.R. Staphylococci. Gorbach S.L., Bartlett J.G., Blacklow N.R. Infectious diseases. 2nd edition :1998;1697-1703 WB Saunders, Philadelphia
5. Waldvogel F.A. Staphylococcus aureus (including staphylococcal toxic shock). Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious disease. 5th edition :2000;2069-2092 Churchill Livingstone, Philadelphia
6. Takahashi N., Kato H., Imanishi K., Miwa K., Yamanami S., Nishida H., et al. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J Clin Invest. 106:(11):2000;1409-1415
7. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., Davies H.D. Population-based study of the epidemiology and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 187:(9):2003;1452-1459
8. Bannerman T.L. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., Yolken R.H. Manual of clinical microbiology. 8th edition :2003;384-404 ASM Press, Washington, DC
9. Solberg C.O. Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand J Infect Dis. 32:(6):2000;587-595
10. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 21:(8):2000;510-515
11. Linares J. The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect. 7:(Suppl 4):2001;8-15
12. Kluytmans J., vanBelkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 10:(3):1997;505-520
13. Elsayed S. Staphylococcus aureus (MRSA detection). Fuchs J., Podda M. Encyclopedia of medical genomics and proteomics. 1st edition :2004;Dekker, New York. (in press)
14. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet. 2:(8100):1978;1116-1118
15. Laupland K.B., Davies H.D. Toxic shock syndromes. Rello J., Valles J., Kollef M.H. Critical care infectious diseases textbook. 1st edition :2001;461-471 Kluwer, Boston
16. Stevens D.L. The toxic shock syndromes. Infect Dis Clin North Am. 10:(4):1996;727-746
17. Shands K.N., Schmid G.P., Dan B.B., Blum D., Guidotti R.J., Hargrett N.T., et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl Med. 303:(25):1980;1436-1442
18. Centers for Disease Control and Prevention. Case definitions for public health surveillance. MMWR Recomm Rep. 39:(RR-13):1990;1-43
19. Kikuchi K., Takahashi N., Piao C., Totsuk K., Nishida H., Uchiyama T. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol. 41:(7):2003;3001-3006
20. van der Mee-Marquet N., Lina G., Quentin R., Yaouanc-Lapalle H., Fievre C., Takahashi N., et al. Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists. J Clin Microbiol. 41:(10):2003;4883-4884
21. Peters G., Gotz F. Colonization of medical devices by coagulase-negative staphylococci. Waldvogel F.A., Bisno A.L. Infections associated with indwelling devices. 3rd edition :2000;55-88 ASM Press, Washington, DC
22. Christensen G.D., Simpson W.A., Bison A.L., Beachey E.H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 37:(1):1982;318-326
23. Von Eiff C., Peters G., Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2:(11):2002;677-685
24. Hussain Z., Stoakes L., Massey V., Diagre D., Fitzgerald V., Elsayed S., et al. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol. 38:(2):2000;752-754
25. Bouza E., Burillo A., Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Eur J Clin Microbiol Infect Dis. 8:(5):2002;265-274
26. Dobbins B.M., Kite P., Wilcox M.H. Diagnosis of central venous catheter related sepsis - a critical look inside. J Clin Pathol. 52:(3):1999;165-172
27. Richards M., Edwards J., Culver D., Gaynes R. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 21:(8):2000;510-515
28. Bisno A.L., Stevens D.L. Streptococccus pyogenes (including staphylococcal toxic shock syndrome and necrotizing fasciitis). Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious disease. 5th edition :2000;2101-2117 Churchill Livingstone, Philadelphia
29. Stevens D.L. The flesh-eating bacterium: what's next? J Infect Dis. 179:(Suppl 2):1999;S366-S374
30. Krause R. Evolving microbes and re-emerging streptococcal disease. Clin Lab Med. 22:(4):2002;835-848
31. Davies H.D., McGeer A., Schwartz B., Green K., Cann D., Simor A.E., et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 335:(8):1996;547-554
32. Spencer R.C. Invasive streptococci. Eur J Clin Microbiol Infect Dis. 14:(Suppl 1):1995;26-32
33. O'Brien K.L., Levin O.S., Schwartz B. The changing epidemiology of group A Streptococcus infections. Semin Pediatr Infect Dis. 8:(1):1997;10-16
34. Stevens D.L. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1:(3):1995;69-78
35. Ruoff K.L., Whiley A., Beighton D. Streptococcus. Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., Yolken R.H. Manual of clinical microbiology. 8th edition :2003;405-421 ASM Press, Washington, DC
36. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 269:(3):1993;390-391
37. Wessels M.R., Kasper D.L. Group B Streptococcus. Gorbach S.L., Bartlett J.G., Blacklow N.R. Infectious diseases. 2nd edition :1998;1731-1736 WB Saunders, Philadelphia
38. Fernandez M., Baker C.J. Group B streptococcal infections. Semin Pediatr Infect Dis. 10:(2):1999;104-110
39. Farley M.M., Harvey R.C., Stull T., Smith J.D., Schuchat A., Wenger J.D., et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 328:(25):1993;1807-1811
40. Munoz P., Llancaqueo A., Rodriguez-Creixems M., Pelaez T., Martin L., Bouza E. Group B Streptococcus bacteremia in nonpregnant adults. Arch Intern Med. 157:(2):1997;213-216
41. Trivalle C., Martin E., Martel P., Jacque B., Menard J.F., Lemeland J.F. Group B streptococcal bacteraemia in the elderly. J Med Microbiol. 47:(7):1998;649-652
42. Johnson C.C., Tunkel A.R. Viridans streptococci and groups C and G streptococci. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious disease. 5th edition :2000;2167-2183 Churchill Livingstone, Philadelphia
43. Williams G.S. Group C and G streptococci infections: emerging challenges. Clin Lab Sci. 16:(4):2003;209-213
44. Bradley S.F., Gordon J.J., Baumgartner D.D., Marasco W.A., Kauffman C.A. Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis. 13:(2):1991;270-280
45. Salata R.A., Lerner P.I., Shlaes D.M., Gopalakrishna K.B., Wolinsky E. Infections due to Lancefield group C streptococci. Medicine (Baltimore). 68:(4):1989;225-239
46. Pier G.B., Madin S.H. Streptococcus iniae sp. nov., a beta-hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Int J Syst Bacteriol. 26:1976;545-553
47. Weinstein M., Low D., McGeer A., Willey B., Rose D., Coulter M., et al. Invasive infection due to Streptococcus iniae: a new or previously unrecognized disease - Ontario, 1995-1996. Can Commun Dis Rep. 22:(15):1996;129-131
48. Weinstein M.R., Litt M., Kertesz D.A., Wyper P., Rose D., Coulter M., et al. Invasive infections due to a fish pathogen, Streptococcus iniae. N Engl J Med. 337:(9):1997;589-594
49. Lau S.K.P., Woo P.C.Y., Tse H., Leung K.-W., Wong S.S.Y., Yuen K.-Y. Invasive Streptococcus iniae infections outside North America. J Clin Microbiol. 41:(3):2003;1004-1009
50. Goh S.H., Driedger D., Gillett S., Low D.E., Hemmingsen S.M., Amos M., et al. Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol. 36:(7):1998;2164-2166